Aurobindo gets USFDA nod to market generic Osteoporosis drug
Aurobindo Pharma today said it has received final approval from USFDA to manufacture and market generic version of Risedronate Sodium tablets, used in the treatment of Osteoporosis, in the American market.
Dec 01, 2015, 20:42 PM ISTAurobindo gets tentative nod from USFDA for Lacosamide tablets
Drug firm Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy patients.
Mar 19, 2015, 17:32 PM IST